VEMURAFENIB for Remission not achieved: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 10 adverse event reports in the FDA FAERS database where VEMURAFENIB was used for Remission not achieved.
Most Reported Side Effects for VEMURAFENIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Rash | 1,202 | 14.0% | 52 | 239 |
| Arthralgia | 783 | 9.2% | 27 | 79 |
| Off label use | 782 | 9.1% | 90 | 120 |
| Fatigue | 773 | 9.0% | 37 | 122 |
| Diarrhoea | 655 | 7.7% | 51 | 225 |
| Nausea | 601 | 7.0% | 46 | 137 |
| Pyrexia | 569 | 6.7% | 33 | 299 |
| Death | 505 | 5.9% | 504 | 37 |
| Alopecia | 445 | 5.2% | 8 | 32 |
| Decreased appetite | 383 | 4.5% | 22 | 79 |
| Vomiting | 342 | 4.0% | 36 | 141 |
| No adverse event | 341 | 4.0% | 3 | 2 |
| Photosensitivity reaction | 321 | 3.8% | 20 | 64 |
| Pruritus | 305 | 3.6% | 13 | 54 |
| Sunburn | 292 | 3.4% | 7 | 24 |
Other Indications for VEMURAFENIB
Malignant melanoma (2,548)
Product used for unknown indication (2,079)
Metastatic malignant melanoma (1,848)
Hairy cell leukaemia (236)
Neoplasm malignant (188)
Langerhans' cell histiocytosis (146)
Thyroid cancer (119)
Colon cancer (110)
Erdheim-chester disease (108)
Malignant melanoma stage iv (88)